Oral ezatiostat HCl (Telintra®, TLK199) and idiopathic chronic neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with... von Lyons, Roger M, Wilks, Sharon T, Young, Shelby, Brown, Gail L

Volltext

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodyspla... von Raza, Azra, Galili, Naomi, Callander, Natalie, Ochoa, Leonel, Piro, Lawrence, Emanuel, Peter, Williams, Stephanie, Burris, 3rd, Howard, Faderl, Stefan, Estrov, Zeev, Curtin, Peter, Larson, Richard A, Keck, James G, Jones, Marsha, Meng, Lisa, Brown, Gail L

Volltext

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) von Raza, Azra, Galili, Naomi, Mulford, Deborah, Smith, Scott E, Brown, Gail L, Steensma, David P, Lyons, Roger M, Boccia, Ralph, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Mesa, Ruben A

Volltext

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer von Kavanagh, John J, Levenback, Charles F, Ramirez, Pedro T, Wolf, Judith L, Moore, Carla L, Jones, Marsha R, Meng, Lisa, Brown, Gail L, Bast, Jr, Robert C

Volltext

Phase 1 Study of TLK286 (Telcyta) Administered Weekly in Advanced Malignancies von ROSEN, Lee S, LAXA, Bernadette, BOULOS, Leny, WIGGINS, Laura, KECK, James G, JAMESON, Anneliese J, PARRA, Richard, PATEL, Kiran, BROWN, Gail L

Volltext

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome von Raza, Azra, Galili, Naomi, Smith, Scott E., Godwin, John, Boccia, Ralph V., Myint, Han, Mahadevan, Daruka, Mulford, Deborah, Rarick, Mark, Brown, Gail L., Schaar, Dale, Faderl, Stefan, Komrokji, Rami S., List, Alan F., Sekeres, Mikkael

Volltext

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome von Raza, Azra, Galili, Naomi, Smith, Scott, Godwin, John, Lancet, Jeffrey, Melchert, Magda, Jones, Marsha, Keck, James G., Meng, Lisa, Brown, Gail L., List, Alan

Volltext

Phase I Study of TLK286 (Glutathione S-Transferase P1-1 Activated Glutathione Analogue) in Advanced Refractory Solid Malignancies von ROSEN, Lee S, BROWN, Joseph, MASCAVAGE, Julie C, DOMBROSKI, Jacqueline A, GOMEZ, Reinaldo F, BROWN, Gail L, LAXA, Bernadette, BOULOS, Leny, REISWIG, Laura, HENNER, William D, LUM, Robert T, SCHOW, Steve R, MAACK, Christopher A, KECK, James G

Volltext

Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer von Sequist, Lecia V., Fidias, Panos M., Temel, Jennifer S., Kolevska, Tatjana, Rabin, Michael S., Boccia, Ralph V., Burris, Howard A., Belt, Robert J., Huberman, Mark S., Melnyk, Ostap, Mills, Glenn M., Englund, Craig W., Caldwell, David C., Keck, James G., Meng, Lisa, Jones, Marsha, Brown, Gail L., Edelman, Martin J., Lynch, Thomas J.

Volltext

Abstract PR08: Antitumor activity and immune correlates of PEGylated human IL-10 (AM0010) alone or in combination with anti-PD-1 von Naing, Aung, Infante, Jeffrey R., Papadopoulos, Kyriakos P., Wong, Deborah J., Autio, Karen A., Falchook, Gerald S., Patel, Manish, Pant, Shubham, Patnaik, Amita, Whiteside, Melinda, Bendell, Johanna C., Mumm, John, Chan, Ivan H., Brown, Gail L., VanVlasselaer, Peter, Hecht, J. R., Hong, David S., Tannir, Nizar M., Oft, Martin

Volltext

Oral ezatiostat HCl inhibitor von Lyons, Roger M, Wilks, Sharon T, Young, Shelby, Brown, Gail L

Volltext

Oral ezatiostat HCl von Brown, Gail L, Lyons, Roger M, Young, Shelby, Wilks, Sharon T

Volltext

Multi‐institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S‐transferase P1‐1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or... von KAVANAGH, J.J., GERSHENSON, D.M., CHOI, H., LEWIS, L., PATEL, K., BROWN, G.L., GARCIA, A., SPRIGGS, D.R.

Volltext

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion von Raza, Azra, Galili, Naomi, Mulford, Deborah, Smith, Scott E, Brown, Gail L, Steensma, David P, Lyons, Roger M, Boccia, Ralph, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Mesa, Ruben A

Volltext

Phase 1 Dose Escalation Study of TLK199 Tablets (Telintra), a Novel Glutathione Analog, in Myelodysplastic Syndrome von Raza, Azra, Melcert, Magda, Galili, Naomi, Smith, Scott E., Godwin, John E., Young, Shelby, Meng, Lisa, Jones, Marsha, Brown, Gail L., Lancet, Jeffery, List, Alan

Volltext

Telintra™ (TLK199) Enhances Granulocyte Colony-Stimulating Factor Production von Stofega, Mary R., Cheng, Mingshan, Ma, Huiping, Sambucetti, Lidia, Keck, James G., Brown, Gail L., Cai, Danying

Volltext

DOSAGES FOR HDAC TREATMENT WITH REDUCED SIDE EFFECTS von BROWN, Gail L, WARREN, Marshelle Smith, SLACK, David, TRAUGER, Richard, MCRAE, Robert

Volltext bestellen

DOSAGES FOR HDAC TREATMENT WITH REDUCED SIDE EFFECTS von BROWN, Gail L, WARREN, Marshelle Smith, SLACK, David, TRAUGER, Richard, MCRAE, Robert

Volltext bestellen

METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS von WARREN, Marshelle, Smith, SLACK, David, TRAUGER, Richard, BROWN, Gail, L, DENG, Xiaohu, MCRAE, Robert

Volltext bestellen

Hematologic Improvement (HI) by TLK199 (Telintra™), a Novel Glutathione Analog, in Myelodysplastic Syndrome: Phase 2 Study Results von Raza, Azra, Callander, Natalie, Ochoa, Leonel, Piro, Lawrence, Emanuel, Peter, Guba, Susan, Shapiro, Gabriel, Williams, Stephanie, Burris, Howard, Faderl, Stefan, Estrov, Zeev, Curtain, Peter, Larson, Richard, Young, Shelby, Brown, Gail L.

Volltext